These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

618 related articles for article (PubMed ID: 29763365)

  • 21. Etelcalcetide, A Novel Calcimimetic, Prevents Vascular Calcification in A Rat Model of Renal Insufficiency with Secondary Hyperparathyroidism.
    Yu L; Tomlinson JE; Alexander ST; Hensley K; Han CY; Dwyer D; Stolina M; Dean C; Goodman WG; Richards WG; Li X
    Calcif Tissue Int; 2017 Dec; 101(6):641-653. PubMed ID: 29038882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exogenous BMP7 in aortae of rats with chronic uremia ameliorates expression of profibrotic genes, but does not reverse established vascular calcification.
    Gravesen E; Lerche Mace M; Nordholm A; Hofman-Bang J; Hruska K; Haagen Nielsen C; Kjær A; Olgaard K; Lewin E
    PLoS One; 2018; 13(1):e0190820. PubMed ID: 29304096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of phosphorus-restricted diet and phosphate-binding therapy on outcomes in patients with chronic kidney disease.
    Russo D; Bellasi A; Pota A; Russo L; Di Iorio B
    J Nephrol; 2015 Feb; 28(1):73-80. PubMed ID: 24599830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blockage of the renin-angiotensin system attenuates mortality but not vascular calcification in uremic rats: sevelamer carbonate prevents vascular calcification.
    Tokumoto M; Mizobuchi M; Finch JL; Nakamura H; Martin DR; Slatopolsky E
    Am J Nephrol; 2009; 29(6):582-91. PubMed ID: 19145073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identifying early pathogenic events during vascular calcification in uremic rats.
    Hortells L; Sosa C; Guillén N; Lucea S; Millán Á; Sorribas V
    Kidney Int; 2017 Dec; 92(6):1384-1394. PubMed ID: 28844316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lanthanum carbonate, like sevelamer-HCl, retards the progression of vascular calcification and atherosclerosis in uremic apolipoprotein E-deficient mice.
    Nikolov IG; Joki N; Nguyen-Khoa T; Guerrera IC; Maizel J; Benchitrit J; Machado dos Reis L; Edelman A; Lacour B; Jorgetti V; Drüeke TB; Massy ZA
    Nephrol Dial Transplant; 2012 Feb; 27(2):505-13. PubMed ID: 21705467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disturbances in Bone Largely Predict Aortic Calcification in an Alternative Rat Model Developed to Study Both Vascular and Bone Pathology in Chronic Kidney Disease.
    Neven E; Bashir-Dar R; Dams G; Behets GJ; Verhulst A; Elseviers M; D'Haese PC
    J Bone Miner Res; 2015 Dec; 30(12):2313-24. PubMed ID: 26108730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preclinical Pharmacokinetics, Pharmacodynamics and Safety of Sucroferric Oxyhydroxide.
    Cozzolino M; Funk F; Rakov V; Phan O; Teitelbaum I
    Curr Drug Metab; 2014; 15(10):953-65. PubMed ID: 25658128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphate restriction significantly reduces mortality in uremic rats with established vascular calcification.
    Finch JL; Lee DH; Liapis H; Ritter C; Zhang S; Suarez E; Ferder L; Slatopolsky E
    Kidney Int; 2013 Dec; 84(6):1145-53. PubMed ID: 24107846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PA21, a new iron-based noncalcium phosphate binder, prevents vascular calcification in chronic renal failure rats.
    Phan O; Maillard M; Peregaux C; Mordasini D; Stehle JC; Funk F; Burnier M
    J Pharmacol Exp Ther; 2013 Aug; 346(2):281-9. PubMed ID: 23697346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic Kidney Disease Circulating Calciprotein Particles and Extracellular Vesicles Promote Vascular Calcification: A Role for GRP (Gla-Rich Protein).
    Viegas CSB; Santos L; Macedo AL; Matos AA; Silva AP; Neves PL; Staes A; Gevaert K; Morais R; Vermeer C; Schurgers L; Simes DC
    Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):575-587. PubMed ID: 29301790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fetuin-A decrease induced by a low-protein diet enhances vascular calcification in uremic rats with hyperphosphatemia.
    Yamada S; Tokumoto M; Tsuruya K; Tatsumoto N; Noguchi H; Kitazono T; Ooboshi H
    Am J Physiol Renal Physiol; 2015 Oct; 309(8):F744-54. PubMed ID: 26180236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-serum phosphate and parathyroid hormone distinctly regulate bone loss and vascular calcification in experimental chronic kidney disease.
    Carrillo-López N; Panizo S; Alonso-Montes C; Martínez-Arias L; Avello N; Sosa P; Dusso AS; Cannata-Andía JB; Naves-Díaz M
    Nephrol Dial Transplant; 2019 Jun; 34(6):934-941. PubMed ID: 30189026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Very low protein diet enhances inflammation, malnutrition, and vascular calcification in uremic rats.
    Yamada S; Tokumoto M; Tatsumoto N; Tsuruya K; Kitazono T; Ooboshi H
    Life Sci; 2016 Feb; 146():117-23. PubMed ID: 26764234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcitriol combined with high-calcium and high-phosphorus diet induces vascular calcification model in chronic kidney disease rats.
    Wang Y; Han W; Zhong Y; Li W; Liu Q
    Environ Toxicol; 2024 Mar; 39(3):1769-1779. PubMed ID: 38064270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lanthanum carbonate, a phosphate binder, inhibits calcification of implanted aortic allografts in a rat model.
    Kinoshita O; Yamauchi H; Motomura N; Ono M
    Gen Thorac Cardiovasc Surg; 2019 May; 67(5):413-419. PubMed ID: 30374810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials.
    Navaneethan SD; Palmer SC; Craig JC; Elder GJ; Strippoli GF
    Am J Kidney Dis; 2009 Oct; 54(4):619-37. PubMed ID: 19692157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholesterol-Lowering Action of a Novel Nutraceutical Combination in Uremic Rats: Insights into the Molecular Mechanism in a Hepatoma Cell Line.
    Lupo MG; Biancorosso N; Brilli E; Tarantino G; Adorni MP; Vivian G; Salvalaio M; Dall'Acqua S; Sut S; Neutel C; Chen H; Bressan A; Faggin E; Rattazzi M; Ferri N
    Nutrients; 2020 Feb; 12(2):. PubMed ID: 32050453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of a non-calcium-based phosphate binder on fibroblast growth factor 23 in chronic kidney disease.
    Spatz C; Roe K; Lehman E; Verma N
    Nephron Clin Pract; 2013; 123(1-2):61-6. PubMed ID: 23774446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.